[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![FirstSquawk Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::3295423333.png) First Squawk [@FirstSquawk](/creator/twitter/FirstSquawk) on x 386.7K followers
Created: 2025-07-17 05:05:39 UTC

Novartis reported a strong quarter with higher-than-expected net sales and core EPS, though some drug sales like Cosentyx and Promacta/Revolade fell short of estimates.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945711473814315410/c:line.svg)

**Related Topics**
[eps](/topic/eps)
[sales and](/topic/sales-and)
[novartis](/topic/novartis)
[$novnsw](/topic/$novnsw)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/FirstSquawk/status/1945711473814315410)